Accessibility Menu
Vitura Health Ltd logo

Vitura Health Ltd(ASX) VIT

Market CapA$15.91MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)-92%
5 Year-79%
1 Year-65%
1 Month-23%
A$0.02
+0.00%
+0.00Today
Vitura Health Ltd last closing stock price
MetricPriceDate
Last closeAUD 0.022026-08-13
Vitura Health Ltd stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%AUD 0.022026-08-06
1 month-22.58%AUD 0.032026-07-14
3 month-35.14%AUD 0.042026-05-15
Year to date-60.66%AUD 0.062025-12-31
1 year-64.69%AUD 0.072025-08-13
3 year-94.16%AUD 0.412023-08-14
5 year-79.34%AUD 0.122021-08-13
Since inception-92.41%AUD 0.322019-11-07

Vitura Health Ltd Financials at a Glance

Market Cap

A$15.91MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$255.80M

Net Income (TTM)

A$2.73M

EPS (TTM)

A$0.00

P/E Ratio

20.00

Dividend

A$0.00

Beta (Volatility)

-0.01 (Low)

Price

A$0.02

Volume

0

Open

A$0.03

Previous Close

A$0.02

Daily Range

A$0.02 - A$0.03

52-Week Range

A$0.02 - A$0.07

Estimated Earnings Date

Aug 26, 2026

VIT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Vitura Health Ltd

Vitura Health Limited is a dynamic player in the medicinal cannabis sector, established in 2018 and headquartered in South Yarra, Australia. The company specializes in the supply and marketing of medicinal cannabis products across Australia and the Asian market, managing a diverse portfolio of brands.

Products and Services
  • Medicinal cannabis products tailored for various health needs
  • Key brands include CanView, Burleigh Heads Cannabis, and CDA Clinics
  • Focus on quality and compliance in product offerings
Growth Outlook
  • Revenue increased to AUD 67.87 million in the latest quarter
  • Strong gross profit margin of 27.52% in Q4 2025
  • Expansion plans targeting the Asian market for future growth
Financial Highlights
  • Trailing twelve months (TTM) revenue of AUD 238.5 million
  • Net income of AUD 1.62 million reported in Q4 2025
  • Dividend yield of 7.14% reflects commitment to shareholder returns
Vitura Health Limited has positioned itself as a significant entity in the medicinal cannabis industry, leveraging its established brands and market presence. The recent revenue growth and strong gross profit margins indicate a robust operational performance. The company's strategic focus on expanding into the Asian market presents a promising avenue for future growth. Financially, the company has demonstrated resilience, with a positive net income in the latest quarter and a competitive dividend yield, appealing to potential investors seeking opportunities in the healthcare sector.
AI Generated • Jul 28, 2026

Industry

Pharmaceuticals

CEO

Geoff Cockerill

Headquarters

South Yarra, VIC 3141, AU

VIT Financials

Key Financial Metrics (TTM)

Gross Margin

15.38%

Operating Margin

1.85%

Net Income Margin

0.61%

Return on Equity

1.66%

Return on Capital

8.71%

Return on Assets

1.02%

Earnings Yield

5.00%

Dividend Yield

8.33%

Payout Ratio

1.65%

Stock Overview

Market Cap

A$15.91MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

662.74M

Volume

0

Avg. Volume

427.39K

Financials (TTM)

Gross Profit

A$53.34M

Operating Income

A$5.44M

EBITDA

A$7.64M

Operating Cash Flow

A$1.54M

Capital Expenditure

-A$287.87K

Free Cash Flow

A$1.25M

Cash & ST Invst.

A$6.10M

Total Debt

A$17.34M

Vitura Health Ltd Performance Analysis

Vitura Health Ltd annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30AUD 66,991,732N/A
20232023-06-30AUD 117,343,63375.2%
20242024-06-30AUD 123,870,8685.6%
20252025-06-30AUD 124,036,9700.1%
Vitura Health Ltd sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-306.5%
Q22024-12-31-1.9%
Q42025-06-30-2.1%
Q22025-12-3110.6%
Vitura Health Ltd annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30AUD 0.01N/A
20232023-06-30AUD 0.0295.2%
20242024-06-30AUD 0.01-74.4%
20252025-06-30AUD 0.01-12.9%
Vitura Health Ltd sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30-93.1%
Q22024-12-31625.0%
Q42025-06-30-13.8%
Q22025-12-31-152.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

A$67.87M

+13.2%

Gross Profit

A$2.98M

-63.4%

Gross Margin

4.40%

N/A

Market Cap

A$15.91MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$220.91K

N/A

Employees

72

N/A

Net Income

-A$837.57K

-125.6%

EBITDA

A$1.52M

-72.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

A$6.10M

-53.1%

Total Debt

A$17.34M

+44.0%

Accounts Receivable

A$12.88M

-0.9%

Inventory

A$6.89M

+38.6%

Long Term Debt

A$9.10M

-12.2%

Short Term Debt

A$8.24M

+390.7%

Return on Assets

1.02%

N/A

Return on Invested Capital

4.51%

N/A

Free Cash Flow

-A$1.41M

-121.6%

Operating Cash Flow

-A$1.37M

-120.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IDT.AXIDT Australia Limited
A$0.05+0.00%
BDX.AXBCAL Diagnostics Limited
A$0.06+1.79%
LGP.AXLittle Green Pharma Ltd
A$0.08+1.33%
EMD.AXEmyria Limited
A$0.05+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$8.91-0.09%
SMCISuper Micro Computer
$39.16+0.04%
SPCXSpace Exploration Technologies
$141.29-0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.64+0.07%

Questions About VIT

What is the current price of Vitura Health Ltd?

Vitura Health Ltd is trading at A$0.02 per share.

What is the 52-week range for Vitura Health Ltd?

Over the past 52 weeks, Vitura Health Ltd has traded between A$0.02 and A$0.07.

How much debt does Vitura Health Ltd have?

As of the most recent reporting period, Vitura Health Ltd reported total debt of A$11.97M.

How much cash does Vitura Health Ltd have on hand?

Vitura Health Ltd reported A$7.58M in cash and cash equivalents in its most recent financial results.

What is Vitura Health Ltd’s dividend yield?

Vitura Health Ltd currently has a dividend yield of 8.33%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.